NPS Pharma reports change in tentative date of FDA review of Natpara BLA NPS Pharmaceuticals reported that the U.S. Food and Drug Administration shifted the tentative date for the Natpara Advisory Committee Meeting from July 24 to September 12. A definitive date for the advisory committee meeting is expected to be published by FDA in the Federal Register at least 15 days prior to such meeting. The Prescription Drug User Fee Act Action Date of October 24 remains unchanged.
News For NPSP From The Last 14 Days
Check below for free stories on NPSP the last two weeks.